This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Blankenhorn, D. H. Articles by Azen, S. P. Search for Related Content PubMed PubMed Citation Articles by Blankenhorn, D. H. Articles by Azen, S. P.

Circulation, Vol 86, 1701-1709, Copyright © 1992 by American Heart Association

ARTICLES

Evaluation of colestipol/niacin therapy with computer-derived coronary end point measures. A comparison of different measures of treatment effect

DH Blankenhorn, RH Selzer, WJ Mack, DW Crawford, J Pogoda, PL Lee, AM Shircore and SP Azen
Department of Preventive Medicine, University of Southern California Los Angeles 90033.

BACKGROUND. The Cholesterol Lowering Atherosclerosis Study has demonstrated beneficial effect of colestipol/niacin on coronary atherosclerosis using a panel-determined global coronary change score. We now report treatment group comparisons using quantitative coronary angiographic (QCA) measures from all processable segments in 85 of 162 randomly selected baseline/2-year film pairs. METHODS AND RESULTS. Treatment benefit was established for percent stenosis for either continuous or categorical analyses with regression established regardless of the per-patient scoring procedure. In addition, treatment benefit favoring regression was established in some cases for roughness and for percent involvement, a longitudinal estimate of the percent of coronary surface involved by raised lesions. Benefit on minimum diameter was directly related to whether the segment was proximal to a graft insertion and hemodynamically related to the bypass graft. QCA correlates of panel-determined progression were increases in percent stenosis and numbers of occluded lesions in native arteries and the number of progressing lesions in bypass grafts. CONCLUSIONS. These results demonstrate that a variety of computer measures can be used as end points in coronary angiographic therapy trials, but change in percent stenosis correlates best with visual panel assessments and best reflects the treatment benefit; when treatment effect sizes are moderate to large, the required sample size of coronary angiographic trials can be reduced when QCA is used.

This article has been cited by other articles:

				H. N. Hodis, W. J. Mack, S. P. Azen, R. A. Lobo, D. Shoupe, P. R. Mahrer, D. P. Faxon, L. Cashin-Hemphill, M. E. Sanmarco, W. J. French, et al. Hormone Therapy and the Progression of Coronary-Artery Atherosclerosis in Postmenopausal Women N. Engl. J. Med., August 7, 2003; 349(6): 535 - 545. [Abstract] [Full Text] [PDF]

				P. Angerer, W. Kothny, S. Stork, and C. von Schacky Effect of dietary supplementation with {omega}-3 fatty acids on progression of atherosclerosis in carotid arteries Cardiovasc Res, April 1, 2002; 54(1): 183 - 190. [Abstract] [Full Text] [PDF]

				C. von Schacky, P. Angerer, W. Kothny, K. Theisen, and H. Mudra The Effect of Dietary {omega}-3 Fatty Acids on Coronary Atherosclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial Ann Intern Med, April 6, 1999; 130(7): 554 - 562. [Abstract] [Full Text] [PDF]

				N. C. Poirier, M. Carrier, J. Lesperance, G. Cote, M. Pellerin, L. P. Perrault, and L. C. Pelletier QUANTITATIVE ANGIOGRAPHIC ASSESSMENT OF CORONARY ANASTOMOSES PERFORMED WITHOUT CARDIOPULMONARY BYPASS J. Thorac. Cardiovasc. Surg., February 1, 1999; 117(2): 292 - 297. [Abstract] [Full Text] [PDF]

				M. H. Frick, M. Syvanne, M. S. Nieminen, H. Kauma, S. Majahalme, V. Virtanen, Y. A. Kesaniemi, A. Pasternack, and M.-R. Taskinen Prevention of the Angiographic Progression of Coronary and Vein-Graft Atherosclerosis by Gemfibrozil After Coronary Bypass Surgery in Men With Low Levels of HDL Cholesterol Circulation, October 7, 1997; 96(7): 2137 - 2143. [Abstract] [Full Text]

				S. P. Azen, D. Qian, W. J. Mack, A. Sevanian, R. H. Selzer, C.-R. Liu, C.-H. Liu, and H. N. Hodis Effect of Supplementary Antioxidant Vitamin Intake on Carotid Arterial Wall Intima-Media Thickness in a Controlled Clinical Trial of Cholesterol Lowering Circulation, November 15, 1996; 94(10): 2369 - 2372. [Abstract] [Full Text]

				S. P. Azen, W. J. Mack, L. Cashin-Hemphill, L. LaBree, A. M. Shircore, R. H. Selzer, D. H. Blankenhorn, and H. N. Hodis Progression of Coronary Artery Disease Predicts Clinical Coronary Events : Long-term Follow-up From the Cholesterol Lowering Atherosclerosis Study Circulation, January 1, 1996; 93(1): 34 - 41. [Abstract] [Full Text]